ORIC PHARMACEUTICALS INC (ORIC) Stock Analyst Ratings
USA - NASDAQ:ORIC - US68622P1093 - Common Stock
12.5 USD
+0.04 (+0.32%)
ChartMill assigns a Buy % Consensus number of 89% to ORIC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.77. This target is 50.14% above the current price.
ORIC was analyzed by 18 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about ORIC.
In the previous month the buy percentage consensus was at a similar level.
ORIC was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-14 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-13 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-07-08 | Ladenburg Thalmann | Initiate | Buy |
| 2025-05-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-26 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-02-26 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-06 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | Jones Trading | Initiate | Buy |
| 2024-10-31 | Wells Fargo | Initiate | Overweight |
| 2024-09-23 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-06 | Stifel | Initiate | Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-07-17 | Wedbush | Reiterate | Outperform -> Outperform |
ORIC PHARMACEUTICALS INC / ORIC FAQ
What do analysts expect the price target to be for ORIC PHARMACEUTICALS INC (ORIC)?
18 analysts have analysed ORIC and the average price target is 18.77 USD. This implies a price increase of 50.14% is expected in the next year compared to the current price of 12.5.
What is the consensus rating for ORIC stock?
The consensus rating for ORIC PHARMACEUTICALS INC (ORIC) is 88.8889 / 100 . This indicates that analysts generally have a positive outlook on the stock.